Efficacy of Psychostimulant Drugs for Cocaine Dependence (Q24239994)

4

0 references

author name string

Xavier Castells

1

0 references

Miguel Casas

2

0 references

Xavier Vidal

5

0 references

Dolors Capellà

Cochrane Database of Systematic Reviews

6

0 references

publication date

17 February 2010

0 references

published in

0 references

cites work

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Replacement medication for cocaine dependence: methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Mazindol treatment for cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Treatment of cocaine abuse with mazindol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Combination of the dopaminergic agent, phentermine, and the serotonergic agent, fenfluramine, in the treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Preliminary study of buprenorphine and bupropion for opioid-dependent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Mazindol and cocaine addiction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Acute doses of d-amphetamine and bupropion increase cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Discriminative stimulus effects of cocaine in female versus male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Methadone Treatment of Randomly Selected Criminal Addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Agents in development for the management of cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

The neural basis of addiction: a pathology of motivation and choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

A pilot trial of topiramate for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

New treatments for cocaine dependence: a focused review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Descriptive analysis of cocaine use of methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Cellular and molecular mechanisms of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Abuse potential of bupropion nasal insufflation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Understanding polydrug use: review of heroin and cocaine co-use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Treatment strategies for co-occurring ADHD and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Recreational bupropion abuse in a teenager

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Use of stimulants to treat cocaine and methamphetamine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Effects of acute bupropion administration on locomotor activity in adolescent and adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Cocaine uptake is decreased in the brain of detoxified cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Seizure induced by insufflation of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Concurrent Cannabis Use During Treatment for Comorbid ADHD and Cocaine Dependence: Effects on Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

7 January 2021

Lack of neurotoxic effect of diethylpropion in crack-cocaine abusers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

7 January 2021

Mazindol Augmentation of Antipsychotic Treatment for Schizophrenic Patients with Comorbid Cocaine Abuse or Dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

7 January 2021

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007380.PUB3

7 January 2021

10.1002/14651858.CD007380.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20166094

1 reference

Consolidated OpenCitations Corpus – April 2017